Appeal Letter (Anti-Obesity Medication Coverage Denial)

Date: [Date of letter]

Review Type: [Standard / Expedited] (If expedited, briefly justify medical necessity for rapid review and risk of harm from delay.)

From (Prescriber): [Clinician name], [Credentials], [Specialty], NPI: [NPI] — [Practice name], [Address], Phone: [Phone], Fax: [Fax]

To (Payer): [Plan name], [Appeals/Prior Authorization Department], [Address or Fax]

Patient: [Patient full name], DOB: [DOB], Member ID: [Member ID], Group ID: [Group ID] (if applicable)

Reference: Claim/PA/Reference #: [Reference number], Denial date: [Denial date]

Re: Appeal of denial for [Medication name, formulation, route] at [Dose, frequency] with [Quantity] for [Days supply] for [Indication: chronic weight management / cardiovascular risk reduction in established CVD / moderate-to-severe OSA]

Dear Appeals Reviewer,

Executive Summary and Request

[Appeal summary] (3–5 sentences stating intent to appeal, identifying denial date, medication, and patient. Assert that the patient meets medical necessity and coverage criteria. Include 2–3 compelling patient-specific facts with objective data and dates—current BMI and class, key complications, documented prior treatment failures, or response to therapy if continuation request.)

• Drug: [Generic and brand name, formulation, route]
• Dose: [Titration schedule] → [Maintenance dose]
• Quantity/Days Supply: [Quantity] for [Days supply]
• Requested Authorization Duration: [Duration requested]
• ICD-10 Codes: [Primary ICD-10 code(s)], [Secondary ICD-10 code(s) if applicable]
• On-Therapy Outcomes: (Include only for continuation/reauthorization.) Baseline weight/BMI: [Value, date]; Current weight/BMI: [Value, date]; Percent change: [Percent change]; Duration on therapy: [Duration]; Consequence if interrupted: [Clinical risks of interruption]

Denial Summary and Point-by-Point Rebuttal

Denial reason(s) as stated by payer:

1. [Denial reason 1 — payer language]
2. [Denial reason 2 — payer language]
3. [Denial reason 3 — payer language] (Add or remove items as needed.)

Denial Rationale	Patient-Specific Evidence	Clinical Interpretation	Attachment
[Denial reason #1 — exact or closely paraphrased payer language]	[Relevant objective data with dates addressing #1]	[Evidence-based explanation addressing #1, aligned with policy/guidelines/FDA label]	[Attachment #]
[Denial reason #2]	[Patient-specific facts with dates]	[Clinical interpretation]	[Attachment #]
[Denial reason #3]	[Patient-specific facts with dates]	[Clinical interpretation]	[Attachment #]

(If the denial is a benefit exclusion rather than medical necessity denial, explicitly distinguish this and request exception if plan allows, or clarify a clinically accurate covered indication with supporting documentation.)

Patient Clinical Summary

Anthropometrics and Obesity Severity

Current measurements: Height: [Height]; Weight: [Weight, date]; BMI: [BMI, date]; BMI class: [Class I / Class II / Class III]

Highest documented weight: [Weight, date] (Include if available.)

Chronicity: [Duration of obesity and prior patterns of loss/regain with dates]

Weight trend:

Date	Weight	BMI
[Baseline date]	[Baseline weight]	[Baseline BMI]
[Interim date]	[Interim weight]	[Interim BMI]
[Current date]	[Current weight]	[Current BMI]

(Use clinic-measured values; label as patient-reported if applicable.)

Obesity-Related Complications

• [Complication]: Diagnosed [Date]; [Key objective measures with dates]; Current treatment: [Treatment and control status]
• [Complication]: Diagnosed [Date]; [Key objective measures with dates]; Current treatment: [Treatment and control status]

(List complications justifying AOM therapy such as type 2 diabetes, prediabetes, hypertension, dyslipidemia, OSA, osteoarthritis, NAFLD/MASH, GERD, PCOS, CVD, or heart failure. Include objective data—A1c, BP, lipids, AHI, imaging. If none documented, do not fabricate; emphasize BMI class, trajectory, and functional impact instead.)

Functional Impact

[Functional limitations, mobility issues, exertional intolerance, safety risks] (Include only if documented and clinically relevant; otherwise omit this subsection.)

Prior Weight Management Interventions

Lifestyle Interventions

• Nutrition/behavioral programs: [Program type], [Dates], [Participation/adherence], [Measured outcomes]
• Physical activity: [Type, frequency, duration], [Dates], [Measured outcomes]
• Ongoing plan: [Current lifestyle plan continuing alongside medication]

Prior Anti-Obesity Medications

(Include if applicable or required for step therapy.)

Medication	Dose	Dates of Use	Outcome	Adverse Effects/Intolerance	Reason Stopped
[Drug name]	[Dose]	[Start – End dates]	[Percent weight change / plateau / regain]	[Adverse effects or intolerance]	[Reason stopped]

(Define failure as insufficient response after adequate trial, intolerance, or contraindication.)

Prior Bariatric Surgery

(Include only if applicable; otherwise omit this subsection.)

• Procedure: [Procedure type], [Date]
• Outcomes: [Results, complications, or regain patterns]
• (If considered but not pursued, document reason.)

Requested Medication

• Name: [Generic name] ([Brand name])
• Formulation/Route: [Formulation, route]
• Titration Schedule: [Titration doses and intervals]
• Maintenance Dose: [Target or current stable dose]
• Quantity/Days Supply: [Quantity] for [Days supply]
• Authorization Duration Requested: [Duration]

Indication Alignment

[Statement of how patient meets FDA-labeled indication, payer policy criteria, or evidence-based guideline recommendation] (Reference specific policy section if available. If requesting under alternative indication such as CV risk reduction or OSA, document defining criteria with objective evidence.)

Continuation of Therapy

(Include this section only if the patient is currently on the medication or denial interrupts ongoing therapy; otherwise omit entirely.)

Therapy details: Started [Start date]; Current dose: [Dose]; Adherence: [Adherence summary]; Tolerability: [Tolerability summary]

Metric	Baseline	Current	Change
Weight	[Baseline weight, date]	[Current weight, date]	[Absolute and percent change]
BMI	[Baseline BMI]	[Current BMI]	[Change]
[Complication metric]	[Baseline value, date]	[Current value, date]	[Change]

Medical necessity of continuation: [Expected harm if therapy stopped—weight regain, recurrence of complication symptoms, loss of cardiometabolic improvements—linked to patient's documented history of relapse when applicable] (If numeric continuation criteria not met due to treatment interruption or titration delays, explain reason and provide clinical plan.)

Safety and Monitoring Plan

• Contraindication screening: [Relevant contraindications screened and negative/managed]
• Pregnancy status: [Documentation and counseling if applicable]
• Risk mitigation: [Dose escalation approach, anticipated side effect management, hypoglycemia precautions if applicable]
• Follow-up plan: [Schedule for weight, vitals, and lab monitoring]

Medical Necessity Statement

[Medical necessity narrative] (1–2 paragraphs synthesizing: obesity as a chronic, relapsing disease in this patient; why lifestyle intervention alone is insufficient based on documented attempts and clinical risk; why the requested medication is appropriate now—aligned with indication and criteria, addresses documented complications or reduces established risk; why alternatives are ineffective, inappropriate, or unsafe for this patient; expected outcomes and follow-up plan. Use evidence-based framing. Avoid adversarial language; prefer phrasing such as "the denial does not reflect the documented criteria.")

Request for Reconsideration

I respectfully request reversal of the denial and authorization for [Medication, dose, quantity, duration].

Peer-to-peer review: [Availability and best contact number] (Include if offered by payer.)

Expedited review: [Turnaround needed and clinical justification] (Include only if medically necessary.)

Thank you for your consideration of this appeal.

Sincerely,

Signature

Signature: [Clinician signature]

Printed Name: [Clinician name], [Credentials]

NPI: [NPI]

Practice: [Practice name]

Contact: Phone: [Phone] | Fax: [Fax]

Date: [Date signed]

Attachments

1. Payer denial notice (Reference #: [Reference number], Date: [Denial date])
2. [Relevant progress notes]
3. [Weight/BMI trend summary]
4. [Pertinent labs and diagnostic tests]
5. [Medication history documenting prior AOM trials]
6. [Lifestyle program documentation]
7. [Policy excerpts or guideline pages] (if applicable)

(Reference each attachment in the rebuttal crosswalk and clinical summary. Include only documentation necessary to support the appeal.)